Table of Contents

Introduction

Select this article
- Itamar Raz
Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Dilemmas in clinical practice
Diabetes Care November 2009 32:S149-S150; doi:10.2337/dc09-S300

Hypertension and Diabetes Debates

Select this article
- Avshalom Leibowitz and
- Ehud Grossman
How to Define Prehypertension in Diabetes/Metabolic Syndrome
Diabetes Care November 2009 32:S275-S279; doi:10.2337/dc09-S323
Select this article
- Ehud Grossman
Should We Treat Prehypertension in Diabetes?: What are the cons?
Diabetes Care November 2009 32:S280-S283; doi:10.2337/dc09-S324
Select this article
- Julian Segura and
- Luis M. Ruilope
Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?
Diabetes Care November 2009 32:S284-S289; doi:10.2337/dc09-S325
Select this article
- Peter M. Nilsson
Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?
Diabetes Care November 2009 32:S290-S293; doi:10.2337/dc09-S329
Select this article
- Roland E. Schmieder
Hypertension and Diabetes: What are the pros to treating early surrogates?
Diabetes Care November 2009 32:S294-S297; doi:10.2337/dc09-S356
Select this article
- Gianfranco Parati and
- Grzegorz Bilo
Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
Diabetes Care November 2009 32:S298-S304; doi:10.2337/dc09-S326
Select this article
- Giuseppe Mancia,
- Roberto Sega,
- Michele Bombelli,
- Fosca Quarti-Trevano,
- Rita Facchetti,
- and Guido Grassi
Should White-Coat Hypertension in Diabetes Be Treated? Pro
Diabetes Care November 2009 32:S305-S309; doi:10.2337/dc09-S327
Select this article
- Michael Bursztyn and
- Iddo Z. Ben-Dov
White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Diabetes Care November 2009 32:S310-S313; doi:10.2337/dc09-S328

Obesity and Lipids

Select this article
- Eduardo Esteve,
- Wifredo Ricart,
- and José Manuel Fernández-Real
Adipocytokines and Insulin Resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin
Diabetes Care November 2009 32:S362-S367; doi:10.2337/dc09-S340
Select this article
- Francesco Rubino,
- Tracy-Ann Moo,
- Daniel J. Rosen,
- Greg F. Dakin,
- and Alfons Pomp
Diabetes Surgery: A New Approach to an Old Disease
Diabetes Care November 2009 32:S368-S372; doi:10.2337/dc09-S341
Select this article
- Rafael Bitzur,
- Hofit Cohen,
- Yehuda Kamari,
- Aviv Shaish,
- and Dror Harats
Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?
Diabetes Care November 2009 32:S373-S377; doi:10.2337/dc09-S343
Select this article
- Yehuda Kamari,
- Rafael Bitzur,
- Hofit Cohen,
- Aviv Shaish,
- and Dror Harats
Should All Diabetic Patients Be Treated With a Statin?
Diabetes Care November 2009 32:S378-S383; doi:10.2337/dc09-S344
Select this article
- Roy Eldor and
- Itamar Raz
American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
Diabetes Care November 2009 32:S384-S391; doi:10.2337/dc09-S345
Select this article
- Vojtech Hainer,
- Hermann Toplak,
- and Vladimír Stich
Fat or Fit: What Is More Important?
Diabetes Care November 2009 32:S392-S397; doi:10.2337/dc09-S346
Select this article
- Etty Osher and
- Naftali Stern
Obesity in Elderly Subjects: In sheep's clothing perhaps, but still a wolf!
Diabetes Care November 2009 32:S398-S402; doi:10.2337/dc09-S347
Select this article
- Ioannis Kyrou and
- Constantine Tsigos
Obesity in the Elderly Diabetic Patient: Is weight loss beneficial? No
Diabetes Care November 2009 32:S403-S409; doi:10.2337/dc09-S348

Diagnosis and Treatment of Microvascular Disease

Select this article
- Mordchai Ravid
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
Diabetes Care November 2009 32:S410-S413; doi:10.2337/dc09-S349
Select this article
- Dan Ziegler
Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
Diabetes Care November 2009 32:S414-S419; doi:10.2337/dc09-S350
Select this article
- Yoram Vardi
Microvascular Complications in Diabetic Erectile Dysfunction: Do we need other alternatives?
Diabetes Care November 2009 32:S420-S422; doi:10.2337/dc09-S351

Smoking

Select this article
- Peter M. Nilsson and
- Karl-Olov Fagerström
Smoking Cessation: It Is Never Too Late
Diabetes Care November 2009 32:S423-S425; doi:10.2337/dc09-S352
Select this article
- David M. Mannino
Why Won't Our Patients Stop Smoking?: The power of nicotine addiction
Diabetes Care November 2009 32:S426-S428; doi:10.2337/dc09-S353
Select this article
- Robert H. Fagard
Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes
Diabetes Care November 2009 32:S429-S431; doi:10.2337/dc09-S354

Diabetes Care

Introduction

Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Dilemmas in clinical practice

Diabetes Progression, Prevention, and Treatment

Progression/Prevention

Defining and Characterizing the Progression of Type 2 Diabetes

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver

Viewpoints on the Way to the Consensus Session: Where does insulin resistance start? The adipose tissue

Where Does Insulin Resistance Start?: The brain

Goals of Treatment for Type 2 Diabetes: β-Cell preservation for glycemic control

Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy

Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes

Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes

Target for Glycemic Control: Concentrating on glucose

Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes

Telemedical Artificial Pancreas: PARIS (Páncreas Artificial Telemédico Inteligente) research project

Treatment

Changing the Treatment Paradigm for Type 2 Diabetes

Incretin-Based Therapies: Viewpoints on the way to consensus

Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults

Insulin Therapy for Type 2 Diabetes

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond

Early Insulin Treatment in Type 2 Diabetes: What are the pros?

Early Insulin Use in Type 2 Diabetes: What are the cons?

Hypertension and Diabetes Debates

How to Define Prehypertension in Diabetes/Metabolic Syndrome

Should We Treat Prehypertension in Diabetes?: What are the cons?

Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?

Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?

Hypertension and Diabetes: What are the pros to treating early surrogates?

Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?

Should White-Coat Hypertension in Diabetes Be Treated? Pro

White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes

Diabetes and Cardiovascular Disease

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease

Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes

Glucose Control and Cardiovascular Disease: Is it important? No

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes

Shifting the Disease Management Paradigm From Glucose: What are the pros?

Shifting the Disease Management Paradigm From Glucose: What are the cons?

A Summary of the ADVANCE Trial

Obesity and Lipids

Adipocytokines and Insulin Resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin

Diabetes Surgery: A New Approach to an Old Disease

Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?

Should All Diabetic Patients Be Treated With a Statin?

American Diabetes Association Indications for Statins in Diabetes: Is there evidence?

Fat or Fit: What Is More Important?

Obesity in Elderly Subjects: In sheep's clothing perhaps, but still a wolf!

Obesity in the Elderly Diabetic Patient: Is weight loss beneficial? No

Diagnosis and Treatment of Microvascular Disease

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy

Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?

Microvascular Complications in Diabetic Erectile Dysfunction: Do we need other alternatives?

Smoking

Smoking Cessation: It Is Never Too Late

Why Won't Our Patients Stop Smoking?: The power of nicotine addiction

Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes

This Issue

Current Issue

From the Cover